Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IASIS Technologies is a medical technology company that developed and commercializes the IASIS Micro Current Neurofeedback (MCN) system. This non-invasive technology utilizes low-intensity, transcranial electrical stimulation to facilitate brain 're-regulation' and improve neurological function. Unlike traditional neurofeedback, the IASIS MCN system requires no active effort from the patient, delivering brief micro-current pulses that help the brain shift out of stuck patterns. The technology is primarily indicated for treating traumatic brain injury (TBI), PTSD, anxiety, and depression. IASIS Technologies provides its platform to licensed healthcare practitioners and continues to expand its clinical applications within the fields of neurology and psychiatry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IASIS Technologies.